Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
Clinical trial NCT03617731 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03617731
- Sponsor
- University of Heidelberg Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2028-06-01
- Enrollment
- 662
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.